Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318
In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little a...
Gespeichert in:
Veröffentlicht in: | European journal of immunology 2000-10, Vol.30 (10), p.3012-3020 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3020 |
---|---|
container_issue | 10 |
container_start_page | 3012 |
container_title | European journal of immunology |
container_volume | 30 |
creator | Falk, Kirsten Rötzschke, Olaf Strominger, Jack L. |
description | In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer. |
doi_str_mv | 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72401071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72401071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</originalsourceid><addsrcrecordid>eNqVkdtqGzEQhkVpaZy0r1B0VZKLdWckeQ9uKBj3EEOCCTgXvemg1WpdlT04Ky_FucojFPqGeZJqsZteldIrMdI__z-aj7FzhDECiDc4ERgpVHgqAADhTMIU4VwCiul0tngfLa6ubobqnRzDeL58K6LrJ2z02PaUjUKbikSWwhE79v5bsMniSfacHSFCnEE6GbEvs2br1rZ5uP_hN9a40hluK1e7Rm9d2_C25CtubFV57pqiN7bg-Y63lVu3te3cXai_2lqv11W_dY1r-OnF7IxLiB_uf0pMX7Bnpa68fXk4T9jNxw-r-UV0ufy0mM8uI6MSJaLwDZOkKk9trrUxsSxQFiJFFJlUJoYJlAWqTNiyUDZHoTJtSmUxB5skhZbyhL3e-2669ra3fku188PYurFt7ykRKqwwwX8KMUmkSDMIwtVeaLrW-86WtOlcrbsdIdAAiIZN07Bp2gMiOTzQgIQoAKLfgEgS0HxJgq6D7atDfp_XtvhjeiASBJ_3gu-usrv_Cv1L5uOd_AWBSKqZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17732890</pqid></control><display><type>article</type><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</creator><creatorcontrib>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</creatorcontrib><description>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q</identifier><identifier>PMID: 11069085</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Anergy ; Antigens, Viral - immunology ; Antigens, Viral - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Biopolymers - pharmacology ; CD4-Positive T-Lymphocytes - drug effects ; CD4-Positive T-Lymphocytes - immunology ; Cells, Cultured ; Clonal Anergy ; Cluster ; Drug Evaluation, Preclinical ; Epitopes - immunology ; Epitopes - pharmacology ; Hemagglutinin Glycoproteins, Influenza Virus ; Hemagglutinins, Viral - immunology ; Hemagglutinins, Viral - pharmacology ; High zone tolerance ; Humans ; Immunophenotyping ; Influenza A virus - immunology ; influenza virus ; Lymphocyte Depletion - methods ; MHC ; Peptide Fragments - immunology ; Peptide Fragments - pharmacology ; Peptides - pharmacology</subject><ispartof>European journal of immunology, 2000-10, Vol.30 (10), p.3012-3020</ispartof><rights>2000 WILEY‐VCH Verlag GmbH, Weinheim, Fed. Rep. of Germany</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1521-4141%28200010%2930%3A10%3C3012%3A%3AAID-IMMU3012%3E3.0.CO%3B2-Q$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1521-4141%28200010%2930%3A10%3C3012%3A%3AAID-IMMU3012%3E3.0.CO%3B2-Q$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11069085$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Falk, Kirsten</creatorcontrib><creatorcontrib>Rötzschke, Olaf</creatorcontrib><creatorcontrib>Strominger, Jack L.</creatorcontrib><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</description><subject>Anergy</subject><subject>Antigens, Viral - immunology</subject><subject>Antigens, Viral - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biopolymers - pharmacology</subject><subject>CD4-Positive T-Lymphocytes - drug effects</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>Cells, Cultured</subject><subject>Clonal Anergy</subject><subject>Cluster</subject><subject>Drug Evaluation, Preclinical</subject><subject>Epitopes - immunology</subject><subject>Epitopes - pharmacology</subject><subject>Hemagglutinin Glycoproteins, Influenza Virus</subject><subject>Hemagglutinins, Viral - immunology</subject><subject>Hemagglutinins, Viral - pharmacology</subject><subject>High zone tolerance</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Influenza A virus - immunology</subject><subject>influenza virus</subject><subject>Lymphocyte Depletion - methods</subject><subject>MHC</subject><subject>Peptide Fragments - immunology</subject><subject>Peptide Fragments - pharmacology</subject><subject>Peptides - pharmacology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkdtqGzEQhkVpaZy0r1B0VZKLdWckeQ9uKBj3EEOCCTgXvemg1WpdlT04Ky_FucojFPqGeZJqsZteldIrMdI__z-aj7FzhDECiDc4ERgpVHgqAADhTMIU4VwCiul0tngfLa6ubobqnRzDeL58K6LrJ2z02PaUjUKbikSWwhE79v5bsMniSfacHSFCnEE6GbEvs2br1rZ5uP_hN9a40hluK1e7Rm9d2_C25CtubFV57pqiN7bg-Y63lVu3te3cXai_2lqv11W_dY1r-OnF7IxLiB_uf0pMX7Bnpa68fXk4T9jNxw-r-UV0ufy0mM8uI6MSJaLwDZOkKk9trrUxsSxQFiJFFJlUJoYJlAWqTNiyUDZHoTJtSmUxB5skhZbyhL3e-2669ra3fku188PYurFt7ykRKqwwwX8KMUmkSDMIwtVeaLrW-86WtOlcrbsdIdAAiIZN07Bp2gMiOTzQgIQoAKLfgEgS0HxJgq6D7atDfp_XtvhjeiASBJ_3gu-usrv_Cv1L5uOd_AWBSKqZ</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>Falk, Kirsten</creator><creator>Rötzschke, Olaf</creator><creator>Strominger, Jack L.</creator><general>WILEY‐VCH Verlag GmbH</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200010</creationdate><title>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</title><author>Falk, Kirsten ; Rötzschke, Olaf ; Strominger, Jack L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4742-301c784b8ebaacc63d13d28112934c6050fd1492efd4eb1249acf4e1b0e77da33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anergy</topic><topic>Antigens, Viral - immunology</topic><topic>Antigens, Viral - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biopolymers - pharmacology</topic><topic>CD4-Positive T-Lymphocytes - drug effects</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>Cells, Cultured</topic><topic>Clonal Anergy</topic><topic>Cluster</topic><topic>Drug Evaluation, Preclinical</topic><topic>Epitopes - immunology</topic><topic>Epitopes - pharmacology</topic><topic>Hemagglutinin Glycoproteins, Influenza Virus</topic><topic>Hemagglutinins, Viral - immunology</topic><topic>Hemagglutinins, Viral - pharmacology</topic><topic>High zone tolerance</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Influenza A virus - immunology</topic><topic>influenza virus</topic><topic>Lymphocyte Depletion - methods</topic><topic>MHC</topic><topic>Peptide Fragments - immunology</topic><topic>Peptide Fragments - pharmacology</topic><topic>Peptides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falk, Kirsten</creatorcontrib><creatorcontrib>Rötzschke, Olaf</creatorcontrib><creatorcontrib>Strominger, Jack L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falk, Kirsten</au><au>Rötzschke, Olaf</au><au>Strominger, Jack L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2000-10</date><risdate>2000</risdate><volume>30</volume><issue>10</issue><spage>3012</spage><epage>3020</epage><pages>3012-3020</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>In a previous study we reported that oligomerized T cell epitopes "superactivated" CD4+ T cells. These oligomers, consisting of 12–16 copies of a peptide epitope derived from the hemagglutinin protein of influenza virus (HA306–318), induced a specific T cell response in amounts as little as 5 pg/ml. We now show that the improved antigenicity of these multimerized epitopes can also be utilized to induce "high zone tolerance". Tolerization, similar to activation, occurred at about 3 logs lower concentration of oligomer than of peptide. HA306–318‐specific T cell cultures became nonresponsive to stimulation with peptide after incubation with 0.5–5 μg/ml HA306–318 12‐mer. The nonresponsiveness was accompanied by a drastic down‐regulation of the TCR and by T cell elimination by apoptotic cell death. In contrast, stimulation with peptide even at 50 μg/ml led to temporary induction of anergy. Consequently, induction of tolerance with the oligomer was permanent and no recovery of the cultures was seen in recall experiments 12–14 days after high zone exposure to the 12‐mer.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>11069085</pmid><doi>10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2000-10, Vol.30 (10), p.3012-3020 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_72401071 |
source | MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection) |
subjects | Anergy Antigens, Viral - immunology Antigens, Viral - pharmacology Apoptosis Apoptosis - drug effects Biopolymers - pharmacology CD4-Positive T-Lymphocytes - drug effects CD4-Positive T-Lymphocytes - immunology Cells, Cultured Clonal Anergy Cluster Drug Evaluation, Preclinical Epitopes - immunology Epitopes - pharmacology Hemagglutinin Glycoproteins, Influenza Virus Hemagglutinins, Viral - immunology Hemagglutinins, Viral - pharmacology High zone tolerance Humans Immunophenotyping Influenza A virus - immunology influenza virus Lymphocyte Depletion - methods MHC Peptide Fragments - immunology Peptide Fragments - pharmacology Peptides - pharmacology |
title | Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A28%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antigen%E2%80%90specific%20elimination%20of%20T%20cells%20induced%20by%20oligomerized%20hemagglutinin%20(HA)%20306%E2%80%93318&rft.jtitle=European%20journal%20of%20immunology&rft.au=Falk,%20Kirsten&rft.date=2000-10&rft.volume=30&rft.issue=10&rft.spage=3012&rft.epage=3020&rft.pages=3012-3020&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/1521-4141(200010)30:10%3C3012::AID-IMMU3012%3E3.0.CO;2-Q&rft_dat=%3Cproquest_cross%3E72401071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17732890&rft_id=info:pmid/11069085&rfr_iscdi=true |